Myopia Reports

The “2026 China Ophthalmic Market Report” provides an in-depth examination of one of the world's largest and fastest-growing ophthalmic markets. The report analyzes the demographic, economic, and health care trends shaping future demand while delivering comprehensive insights into disease prevalence, treatment patterns, and market opportunities across 10 key ophthalmic segments. 

Detailed forecasts through 2031 quantify unit demand, market revenue, and growth by product category, while extensive competitive analysis highlights market share dynamics, emerging technologies, commercialized products, and late-stage pipeline assets poised to influence the market. The report also features profiles of leading industry participants, offering valuable perspective on product portfolios, strategic positioning, competitive strengths, and future growth prospects within China's evolving ophthalmic landscape. 

Market Scope’s first-edition “2026 Myopia Management Market Report” provides a data-driven view of one of ophthalmology’s fastest-growing segments, with a focus on the rising pediatric myopia population and the shift toward earlier intervention. It quantifies the total, addressable, and serviceable markets, with five-year forecasts and detailed analysis of treatment volumes, adoption trends, and competitive dynamics across key regions.  

The report provides deep segmentation across all major treatment categories—including myopia control spectacles, soft contact lenses, orthokeratology, and low-dose atropine—alongside insights into combination therapies, treatment efficacy, reimbursement, and barriers to adoption. It also examines the underlying drivers shaping demand, from demographic and lifestyle trends to provider behavior and access to care.  

Expanded coverage of diagnostic technologies, digital platforms, and emerging therapies paired with global market analysis and company profiles gives you a complete picture of where the market is today and where it’s headed.  

Market Scope’s “2025 Myopia Management Survey Report” delivers a comprehensive, provider-level view of how pediatric myopia is being managed in the United States today—examining patient volumes, treatment mix, economics, unmet needs, and how clinical behavior is likely to shift as new therapies reach the market. 

Conducted in August and September 2025, the survey captures insights from 150 US-based optometrists and ophthalmologists, including comprehensive and pediatric specialists actively treating myopia. Respondents were drawn from Market Scope’s self-registered provider community and reflect real-world clinical decision-makers with direct experience in myopia control. 

The report provides a structured summary analysis of de-identified survey data, calculated at the respondent level and presented without market extrapolation to clearly show how providers are thinking, prescribing, pricing, and planning.